Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Category: Pathology


Diabetic Bone Disease and Diabetic Myopathy: Manifestations of the Impaired Muscle-Bone Unit in Type 1 Diabetes

May 13th 2022

This review summarizes several nonmechanical factors that could be mediating the development and progression of premature musculoskeletal decline in this population and discusses preventative measures to reduce the burden of diabetes on the musculoskeletal system (Journal of Diabetes Research)

Categories: News, Pathology
Tags: bone disease, myopathy, Type 1 Diabetes

Categories: Pathology
Tags: bone disease, myopathy, Type 1 Diabetes

Keeping It Local in Metabolic Disease: Adipose Tissue Paracrine Signaling and Insulin Resistance

April 19th 2022

This article highlights the important role of adipose tissue paracrine signaling on metabolic function and insulin sensitivity in nearby tissues and organs, specifically focusing on visceral, pancreatic, subcutaneous, intermuscular, and perivascular adipose tissue depots (Diabetes)

Categories: News, Pathology

Categories: Pathology

Associations between deduced first islet specific autoantibody with sex, age at diagnosis and genetic risk factors in young children with type 1 diabetes

April 11th 2022

Strong differences in sex and age distributions as well as in genetic associations could be observed between GADA- and IAA-initiated autoimmunity (Pediatric Diabetes)

Categories: Genetics, News, Paediatrics, Pathology
Tags: autoantibody, Islet, Type 1 Diabetes

Categories: Genetics, Paediatrics, Pathology
Tags: autoantibody, Islet, Type 1 Diabetes

Impact of Diabetes Mellitus on the Immunity of Tuberculosis Patients: A Retrospective, Cross-Sectional Study

April 7th 2022

Hyperglycemia is a risk factor for pulmonary cavity formation and lobe lesions in patients with TB-DM and suppresses the absolute counts of total T lymphocytes, CD8+ T lymphocytes, and NK cells in patients with TB-DM. The potential mechanism may involve the downregulation of innate and adaptive immune responses (Risk Management and Healthcare Policy)

Categories: News, Pathology
Tags: hyperglycemia, tuberculosis

Categories: Pathology
Tags: hyperglycemia, tuberculosis

Pre-existing diabetic retinopathy as a prognostic factor for covid-19 outcomes amongst people with diabetes: a systematic review

April 5th 2022

The current literature suggests an independent association between DR and poorer COVID-19 prognosis in patients with DM after controlling for key variables such as age (Diabetes Research and Clinical Practice)

Categories: News, Ophthalmology, Pathology
Tags: COVID-19, retinopathy

Categories: Ophthalmology, Pathology
Tags: COVID-19, retinopathy

Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial

April 5th 2022

In this post-hoc analysis of a 4.3-year randomized controlled trial, metformin did not exert a clinically relevant effect on cardiac troponin I and cardiac troponin T levels when compared to placebo. Cardioprotective effects of the drug observed in clinical studies are not reflected by a reduction in these biomarkers of subclinical myocardial injury (Cardiovascular Diabetology)

Categories: Monitoring, News, Pathology
Tags: cardiac troponin, Type 2 Diabetes

Categories: Monitoring, Pathology
Tags: cardiac troponin, Type 2 Diabetes

Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases

March 30th 2022

This systematic review and meta-analysis of RCTs found that use of GLP-1 RAs was associated with increased risk of gallbladder or biliary diseases, especially when used at higher doses, for longer durations, and for weight loss (JAMA Internal Medicine)

Categories: Medication, News, Pathology
Tags: gallbladder, GLP-1 RA

Categories: Medication, Pathology
Tags: gallbladder, GLP-1 RA

Risks and burdens of incident diabetes in long COVID: a cohort study

March 22nd 2022

In the post-acute phase, we report increased risks and 12-month burdens of incident diabetes and antihyperglycaemic use in people with COVID-19 compared with a contemporary control group of people who were enrolled during the same period and had not contracted SARS-CoV-2, and a historical control group from a pre-pandemic era (The Lancet Diabetes & Endocrinology)

Categories: News, Pathology
Tags: COVID-19

Categories: Pathology
Tags: COVID-19

The Gut Microbiome of Adults With Type 1 Diabetes and Its Association With the Host Glycemic Control

March 6th 2022

We identified a distinct gut microbial signature in adults with longstanding T1D and associations between microbial taxa, metabolic pathways, and glycemic control indices (Diabetes Care)

Categories: News, Pathology
Tags: microbiome, Type 1 Diabetes

Categories: Pathology
Tags: microbiome, Type 1 Diabetes

Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes

March 1st 2022

Diabetes diagnosed at COVID-19 presentation is associated with lower glucose but higher inflammatory markers and ICU admission, suggesting stress hyperglycemia as a major physiologic mechanism. Approximately half of such individuals experience regression of DM (Journal of Diabetes and its Complications)

Categories: News, Pathology
Tags: COVID-19

Categories: Pathology
Tags: COVID-19

Glycemic Control and Clinical Outcomes in U.S. Patients With COVID-19: Data From the National COVID Cohort Collaborative (N3C) Database

February 28th 2022

In a large, multicenter cohort of patients in the U.S. with T2D and COVID-19 infection, risk of hospitalization increased with incrementally higher HbA1c levels. Risk of death and invasive ventilation also increased but plateaued at different levels of glycemic control (Diabetes Care)

Categories: News, Pathology
Tags: COVID-19, glycaemic control

Categories: Pathology
Tags: COVID-19, glycaemic control

Joint 30-year HbA1c and lipid trajectories and mortality in type 1 diabetes

February 18th 2022

These results suggest there is a subgroup with type 1 diabetes who, despite poor glycemic control, has a relatively good prognosis, perhaps related to good Non-HDLc (Diabetes Research and Clinical Practice)

Categories: News, Pathology
Tags: glycaemic control, HbA1c, lipid, Type 1 Diabetes

Categories: Pathology
Tags: glycaemic control, HbA1c, lipid, Type 1 Diabetes

The gut hormone glucose-dependent insulinotropic polypeptide is downregulated in response to myocardial injury

February 6th 2022

Circulating GIP levels are downregulated in patients with myocardial infarction and following cardiac surgery. These results might suggest nutrition-independent regulation of GIP secretion following myocardial injury in humans (Cardiovascular Diabetology)

Categories: Cardiovascular, News, Pathology

Categories: Cardiovascular, Pathology

Changes of insulin resistance status and development of complications in type 1 diabetes mellitus: Analysis of DCCT/EDIC study

January 23rd 2022

This study highlights the importance of IR changes represented by eGDR in the development of diabetic complications. Patients with T1D and IR may require intensive therapy (Diabetes Research and Clinical Practice)

Categories: News, Pathology
Tags: Insulin resistance, Type 1 Diabetes

Categories: Pathology
Tags: Insulin resistance, Type 1 Diabetes

Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes

January 20th 2022

In a nationwide cohort of individuals with type 2 diabetes, we found a U-shaped association between HbA1c and sepsis and a fourfold increased risk of death among those developing sepsis (Diabetes Care)

Categories: News, Pathology
Tags: HbA1c, Sepsis, Type 2 Diabetes

Categories: Pathology
Tags: HbA1c, Sepsis, Type 2 Diabetes

Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies

January 18th 2022

Prediabetes was positively associated with risk of all-cause mortality and the incidence of cardiovascular outcomes, CHD, stroke, chronic kidney disease, cancer and dementia (Diabetologia)

Categories: Cardiovascular, Nephropathy, News, Pathology
Tags: prediabetes

Categories: Cardiovascular, Nephropathy, Pathology
Tags: prediabetes

Relative leucocyte telomere length is associated with incident end-stage kidney disease and rapid decline of kidney function in type 2 diabetes: analysis from the Hong Kong Diabetes Register

January 18th 2022

rLTL is independently associated with incident ESKD and rapid eGFR loss in individuals with type 2 diabetes. Telomere length may be a useful biomarker for the progression of kidney function and ESKD in type 2 diabetes (Diabetologia)

Categories: News, Pathology
Tags: leucocyte telomere, Type 2 Diabetes

Categories: Pathology
Tags: leucocyte telomere, Type 2 Diabetes

Elevated serum uric acid is a facilitating mechanism for insulin resistance mediated accumulation of visceral adipose tissue

January 12th 2022

Elevated SUA acts as a mediator inside the bidirectional relationship between IR and VAT accumulation and these observations could be applicable at a phenotype scale (Clinical Endocrinology)

Categories: News, Pathology
Tags: Insulin resistance, uric acid

Categories: Pathology
Tags: Insulin resistance, uric acid

The many faces of diabetes. Is there a need for re-classification? A narrative review

January 9th 2022

This review aims to examine the physiological mechanisms in diabetes, risks for complications, the effects of bariatric and metabolic surgery and will shed light on whether diabetes should be reclassified (BMC Endocrine Disorders)

Categories: News, Pathology
Tags: complications

Categories: Pathology
Tags: complications

Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia

January 6th 2022

Bempedoic acid significantly lowered LDL-C across glycaemic strata and did not worsen glycaemic parameters nor increase incidence of new-onset diabetes vs placebo over a median follow-up of 1 year (Diabetes, Obesity and Metabolism)

Categories: News, Pathology
Tags: bempedoic acid, Type 2 Diabetes

Categories: Pathology
Tags: bempedoic acid, Type 2 Diabetes
  • 1
  • 2
  • 3
  • …
  • 20
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

Napp DiabetesBoehringer IngelheimAstraZenecaNovo Nordisk

Silver Sponsors

Abbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)About Ascensia Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 DPP4 inhibitors elderly Empagliflozin exenatide GLP-1 RA GLP-1RA GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis liraglutide metformin mortality NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2022 Glycosmedia Partnership